Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry

Rymer, J., Alhanti, B., Kemp, S., Bhatt, D. L., Kochar, A., Angiolillo, D. J., Diaz, M., Garratt, K. N., Wimmer, N. J., Waksman, R., Kirtane, A. J., Ang, L., Bach, R., Barker, C., Jenkins, R., Basir, M. B., Sullivan, A., El-Sabae, H., Brothers, L., … Wang, T. Y. (2024). Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry. Journal of the Society for Cardiovascular Angiography & Interventions, 3(2), 101202. https://doi.org/10.1016/j.jscai.2023.101202
Authors:
Jennifer Rymer
Brooke Alhanti
Steven Kemp
Deepak L. Bhatt
Ajar Kochar
Dominick J. Angiolillo
Miguel Diaz
Kirk N. Garratt
Neil J. Wimmer
Ron Waksman
Ajay J. Kirtane
Lawrence Ang
Richard Bach
Colin Barker
Ronald Jenkins
Mir B. Basir
Alex Sullivan
Hijrah El-Sabae
Leo Brothers
E. Magnus Ohman
W. Schuyler Jones
Jeffrey B. Washam
Tracy Y. Wang
Affiliated Authors:
Ajay J. Kirtane
Author Keywords:
p2y12 inhibitor
bleeding
cangrelor
myocardial infarction
p2y<sub>12</sub> inhibitor
Publication Type:
Article
Unique ID:
10.1016/j.jscai.2023.101202
Publication Date:
Data Source:
Scopus

Record Created: